D. Mannino (Lexington, United States of America), A. Johannessen (Bergen, Norway), E. Oelsner (New York, United States of America), E. Fuertes (London, United Kingdom)
Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting H. Whittaker (London, United Kingdom), H. Mullerova (London, United Kingdom), D. Jarvis (London, United Kingdom), N. Barnes (London, United Kingdom), P. Jones (London, United Kingdom), C. Compton (London, United Kingdom), S. Kiddle (Cambridge, United Kingdom), J. Quint (London, United Kingdom)
| |
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations? G. Brozek (Katowice, Poland), N. Nowak (Czosnow k Warszawy, Poland), J. Mateusz (Katowice, Poland), J. Zejda (Katowice, Poland)
| |
Underweight and weight loss are assocaited with greater mortality from chronic obstructive pulmonary disease (COPD) in middle-aged Japanese: The JACC study H. Wada (Tokyo, Japan), A. Ikeda (Tokyo, Japan), K. Maruyama (Tokyo, Japan), K. Yamagishi (Ibaraki, Japan), T. Tanigawa (Tokyo, Japan), A. Tamakoshi (HOkkaido, Japan), H. Iso (Osaka, Japan)
| |
Eligibility for lung volume reduction surgery in COPD patients identified in a UK primary care setting O. Connell (London, United Kingdom), H. Whittaker (London, United Kingdom), A. Elbehairy (London, United Kingdom), J. Campbell (London, United Kingdom), N. Hopkinson (London, United Kingdom), J. Quint (London, United Kingdom)
| |
How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review W. Meeraus (Uxbridge, United Kingdom), V. Benson (Uxbridge, United Kingdom), M. Tabberer (Uxbridge, United Kingdom), W. Fahy (Uxbridge, United Kingdom), H. Mullerova (Uxbridge, United Kingdom)
| |
Clinically relevant differences in COPD health status: systematic review and triangulation H. Alma (Groningen, Netherlands), C. De Jong (Groningen, Netherlands), I. Tsiligianni (Heraklion, Crete, Greece), R. Sanderman (Groningen, Netherlands), J. Kocks (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands)
| |
Lower airway bacterial colonization patterns and species-specific interactions in COPD D. Jacobs (Buffalo, United States of America), H. Ochs-Balcom (Buffalo, United States of America), J. Zhao (Buffalo, United States of America), T. Murphy (Buffalo, United States of America), S. Sethi (Buffalo, United States of America)
| |
Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD U. Nilsson (Umeå, Sweden), A. Blomberg (Umeå, Sweden), N. Mills (Edinburgh, United Kingdom), E. Rönmark (Umeå, Sweden), A. Lindberg (Umeå, Sweden)
| |
Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs) W. Meeraus (Uxbridge, United Kingdom), H. Mullerova (Uxbridge, United Kingdom), M. Tabberer (Uxbridge, United Kingdom), W. Fahy (Uxbridge, United Kingdom), V. Benson (Uxbridge, United Kingdom)
| |
Blood eosinophils and obstructive lung disease in the general population S. Wijnant (Ghent, Belgium), L. Lahousse (Ghent, Belgium), M. De Buyzere (Ghent, Belgium), G. Brusselle (Ghent, Belgium), E. Rietzschel (Ghent, Belgium)
| |
Factors associated with airflow limitation in a population-based cohort of adults from the greater Copenhagen area C. Bårnes (Copenhagen, Denmark), B. Thuesen (Copenhagen, Denmark), A. Linneberg (Copenhagen, Denmark), C. Ulrik (Copenhagen, Denmark)
| |
Sarcopenia in elderly population with chronic respiratory diseases: A population-based study G. Benz I (Rotterdam, Netherlands), K. Trajanoska (Rotterdam, Netherlands), J. Schoufour (Rotterdam, Netherlands), L. Lahousse (Rotterdam, Netherlands), E. De Roos (Rotterdam, Netherlands), N. Terzikhan (Rotterdam, Netherlands), B. Striker (Rotterdam, Netherlands), O. Franco (Rotterdam, Netherlands), F. Rivadeneira (Rotterdam, Netherlands), G. Brusselle (Rotterdam, Netherlands)
| |
Incidence of asthma progression towards asthma-COPD overlap in old women S. Chanoine (Grenoble, France), C. Marchal (Grenoble, France), S. Temam (Villejuif, France), O. Dumas (Villejuif, France), N. Le Moual (Villejuif, France), C. Pison (Grenoble, France), A. Fournier (Villejuif, France), G. Severi (Villejuif, France), M. Boutron-Ruault (Villejuif, France), R. Varraso (Villejuif, France), V. Siroux (Grenoble, France)
| |
Description of the UK’s asthma and COPD inhaler use C. Bloom (London, United Kingdom), I. Douglas (London, United Kingdom), L. Smeeth (London, United Kingdom), J. Quint (London, United Kingdom)
| |
Asthma-COPD overlap syndrome (ACOS) among subjects with newly diagnosed adult-onset asthma M. Jaakkola (Oulu, Finland), Y. Wang (Oulu, Finland), T. Lajunen (Oulu, Finland), C. Lai (Taipei, Taiwan), J. Jaakkola (Oulu, Finland)
| |
Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach K. Kahnert (München, Germany), P. Alter (Marburg, Germany), T. Welte (Hannover, Germany), R. Huber (München, Germany), J. Behr (München, Germany), F. Biertz (Hannover, Germany), H. Watz (Grosshansdorf, Germany), R. Bals (Homburg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (München, Germany)
| |
Association between interpersonal and environmental factors and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD) S. Moitra (Barcelona, Spain), M. Benet (Barcelona, Spain), A. Arbillaga-Etxarri (Barcelona, Spain), A. Marín (Badalona, Spain), A. Barberan-Garcia (Barcelona, Spain), E. Borrell (Badalona, Spain), D. Rodríguez (Barcelona, Spain), E. Gimeno-Santos (Barcelona, Spain), E. Balcells (Barcelona, Spain), M. Koreny (Barcelona, Spain), M. Monteagudo (Barcelona, Spain), P. Torán-Montserrat (Barcelona, Spain), P. Vall-Casas (Barcelona, Spain), R. Rodríguez-Roisin (Barcelona, Spain), J. Garcia-Aymerich (Barcelona, Spain)
| |
C-reactive protein level and risk of developing COPD: The Kangbuk Samsung Cohort Study S. Lim (Seoul, Republic of Korea), D. Zhao (Baltimore, United States of America), E. Guallar (Baltimore, United States of America), Y. Chang (Seoul, Republic of Korea), S. Ryu (Seoul, Republic of Korea), J. Shim (Seoul, Republic of Korea)
| |
Magnitude and characteristics of COPD mortality in Kenya, 2012-2016 G. Kariuki (Nairobi, Kenya), G. Gathecha (Nairobi, Kenya)
| |